Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) currently has a daily average trading volume of 1.67M but it saw 784933 shares traded in last market. With a market cap of 102.89M USD, the company’s current market price of $17.02 came rising about 13.77 while comparing to the previous closing price of $14.96. In past 52 weeks, the stock remained buoying in the range of price level as high as $672.00 and as low as $6.76. In the recent trading on the day, stock has struck highest price mark of $15.3825 while lowest mark touched by it was $17.65.
Taking a look at 20-day trading activity of Tonix Pharmaceuticals Holding Corp (TNXP) gives us an average price of $18.14, while its current price level is -97.47% below from 52-week high level whereas it is 151.78% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $15.37 while that of 200 days or SMA-200 reads an average of $25.37. A closer look into the stock’s movement over the week reveals that its volatility is standing at 8.66% during that period while stretching the period over a month that increases to 14.98%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 49.10 which implies that the stock is in neutral territory.
ROTH Capital upgraded its recommendation for the stock as a “Buy” from “Neutral” on April 18, 2019 while assigning a price target of $4. ROTH Capital issued its recommendations for the stock as it upgraded the price target for the stock is $6.
Over the week, TNXP’s stock price is moving 0.12% up while it is -44.22% when we observe its performance for the past one month. Year-to-date it is -48.39% down and over the past year, the stock is showing a downside performance of -96.68%.
The company is expected to be releasing its next quarterly report on 2025-Mar-17, for which analysts forecasted an EPS of -3.09 while estimate for next year EPS is -11.89. In next quarter, company is expected to be making quarterly sales of $2.65M as analysts are expecting the sales for current fiscal year at $11.1M and seeing the company making $98.7M in sales next year. Moreover, analysts are in estimates of $2.55M for current-quarter revenue.
Currently, Tonix Pharmaceuticals Holding Corp’s total number of outstanding shares is 4.39M with 0.00% of that held by the insiders while 2.71% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -89.94% and return on equity (ROE) at -106.12%. Stock’s beta reads 1.65. Stock has a price to book (P/B) ratio of 0.53 while price to sale or P/S ratio amounts to 10.20. Its return on asset (ROA) is -81.95% on average.
